News
FDA seeks safety data for Lilly's oral GLP-1 Foundayo
The FDA has laid out post-marketing safety testing requirements for Lilly's weight-loss pill Foundayo, including clinical trials.
News
Travere claims first FDA OK in rare kidney disease FSGS
Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare kidney disease FSGS.
News
NICE update doubles eligible patients for AZ's Lokelma
AstraZeneca's hyperkalaemia drug Lokelma could see its use by the NHS more than double thanks to updated guidance from NICE.
News
FDA hands another rejection to Replimune's melanoma therapy
Replimune has had its advanced melanoma treatment RP1 turned down by the FDA for a second time, prompting job losses.
Market Access
For life sciences, it’s not only about when to bring on a GC...
For founders, the question is no longer just who to hire as GC, but when to hire them, and what comes next.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
